Highest Quality Biotechnology Stocks 2026
Top quality Biotechnology stocks in 2026 ranked by Quality of Company score. Multi-factor analysis across 32 fundamental signals updated daily.
Which Biotechnology Stocks Rank Highest by QOC Score?
408 qualifying of 620 biotechnology equities covered.
| # | Ticker | Company | Signal | QOC | Price | QOC Score |
|---|---|---|---|---|---|---|
| 1 | EXEL | Exelixis, Inc. | 9.6 | $55.26 | 9.6/10 | |
| 2 | INCY | Incyte Corporation | 9.5 | $127.74 | 9.5/10 | |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 9.5 | $236.56 | 9.5/10 | |
| 4 | HRMY | Harmony Biosciences Holdings, Inc. | 9.2 | $39.87 | 9.2/10 | |
| 5 | AUPH | Aurinia Pharmaceuticals Inc. | 9.2 | $16.48 | 9.2/10 | |
| 6 | HALO | Halozyme Therapeutics, Inc. | 9.2 | $106.92 | 9.2/10 | |
| 7 | VRTX | Vertex Pharmaceuticals Incorporated | 9.1 | $547.55 | 9.1/10 | |
| 8 | ONC | BeOne Medicines AG | 9.0 | $372.49 | 9.0/10 | |
| 9 | CRMD | CorMedix Inc. | 9.0 | $8.31 | 9.0/10 | |
| 10 | CGEN | Compugen Ltd. | 9.0 | $2.76 | 9.0/10 | |
| 11 | V••• | Vericel ••••• | •.• | $•••.•• | ••.•% | |
| 12 | P••• | Puma ••••• | •.• | $•••.•• | ••.•% | |
| 13 | P••• | PTC ••••• | •.• | $•••.•• | ••.•% | |
| 14 | M••• | MiMedx ••••• | •.• | $•••.•• | ••.•% | |
| 15 | N••• | Niagen ••••• | •.• | $•••.•• | ••.•% | |
| 16 | B••• | BioMarin ••••• | •.• | $•••.•• | ••.•% | |
| 17 | I••• | Innoviva, ••••• | •.• | $•••.•• | ••.•% | |
| 18 | A••• | ADMA ••••• | •.• | $•••.•• | ••.•% | |
| 19 | R••• | Regeneron ••••• | •.• | $•••.•• | ••.•% | |
| 20 | C••• | Corcept ••••• | •.• | $•••.•• | ••.•% |
You’re seeing 10 of 408 qualifying stocks.
Access the complete dataset with 13 institutional-grade models.
How CirclFi Ranks Biotechnology Stocks
CirclFi publishes a valuation page for all 5,877 US equities it covers and can state a 13-model median fair value for the 3,801 with enough filing history for at least two models to run, 164 of them in Biotechnology — reading SEC EDGAR filings, FRED macro data, and GDELT sentiment.
For Biotechnology stocks, CirclFi adjusts sector-relative benchmarks — comparing margins, capital intensity, and growth rates against Biotechnology industry medians.
Profitability Matrix
ROIC, Gross Margin expansion, and FCF Yield analysis.
Growth Vector
Revenue compounding vs. sector benchmarks.
Stability Index
Altman Z-Score, debt resilience, and earnings variance.
What Should You Know About This Biotechnology Screen?
What are the highest quality biotechnology stocks in 2026?
CirclFi identifies the highest quality biotechnology stocks 2026 using 13 institutional-grade valuation models including Bayesian DCF (10,000 Monte Carlo simulations), EPV (Greenwald framework), and EROIC Spread (McKinsey). Rankings update daily from SEC EDGAR filings. The current top-ranked stock is EXEL (Exelixis, Inc.).
How does CirclFi rank Biotechnology stocks?
Stocks are ranked by QOC Score derived from CirclFi's proprietary models. Each model independently processes SEC EDGAR financial data (700+ XBRL tags), FRED macroeconomic indicators, and GDELT news sentiment to produce confidence-weighted fair value estimates. The ranking methodology combines multiple valuation approaches — intrinsic, relative, scenario, and ensemble — for maximum robustness.
How often is the highest quality biotechnology stocks 2026 list updated?
This list is recalculated daily after US market close. Every stock is re-valued through all 13 models using the latest SEC EDGAR filings, market prices, and FRED macroeconomic data. Rankings can change daily as new financial data becomes available or market prices shift relative to fair value estimates.
What is the Quality of Company (QOC) score?
The QOC score is a 0-10 composite rating derived from 32 fundamental signals across four pillars: profitability (ROE, ROIC, margins), growth (revenue CAGR, earnings acceleration), stability (earnings volatility, debt coverage), and capital efficiency (asset turnover, free cash flow yield). Higher scores indicate stronger fundamentals. Scores above 7 represent top-tier companies.
How does this list compare to other stock screeners?
Unlike simple screeners that filter by P/E or dividend yield, CirclFi runs 13 independent institutional-grade valuation models on every stock — including Bayesian DCF with Monte Carlo simulation, Greenwald EPV, and McKinsey economic profit frameworks. Each company is scored on 32 fundamental signals drawn from 700+ SEC EDGAR XBRL tags, then re-valued after every US market close. Most retail screeners use one or two metrics; this screen ranks 620 Biotechnology companies on the median of all 13.